EZH2 recruited DNMT3A to the promoter of ULBP1, increasing DNA methylation and thus down-regulating the expression of NKG2D ligands to resist NK-cell-mediated cytotoxicity in hepatoma cells. Here, ULBP1 is linked to hepatocellular carcinoma.